| Trial name or title |
American College of Surgeons Oncology Group Z0030 Trial |
| Methods |
|
| Participants |
Patients with NSCLC T1‐2, N0‐1(less than hilar), M0. ECOG performance status 0‐2. |
| Interventions |
Eligible participants are assessed intra‐operatively with mediastinal lymph node sampling and frozen section. Those with T1‐2, N0‐1(less than hilar), M0 disease are randomised to either lymph node sampling or complete lymph node dissection intraoperatively |
| Outcomes |
Overall survival. Operative time, post‐operative complications, duration of chest tube drainage and length of hospitalisation. Local recurrence free survival and local‐regional recurrence free survival |
| Starting date |
1999 |
| Contact information |
http://www.acosog.org |
| Notes |
Closed to recruitment |
